Nervovita was founded in İstanbul in 2021 as the regional centre for Türkiye, the Balkans and the Middle East of the German company tVNS Health. It offers vagus nerve stimulation and defibrillation technologies together with sales, regulatory and digital health services, and holds ISO 13485.
Transcutaneous vagus nerve stimulation (tVNS) devices, defibrillation products, tVNS Care digital health services, medical approval and regulatory services.